The largest database of trusted experimental protocols

Gene specific sirna

Manufactured by GenePharma
Sourced in China

Gene-specific siRNAs are laboratory reagents designed to target and silence specific genes. They function by interfering with the expression of target genes, which can be used to study gene function or for therapeutic applications.

Automatically generated - may contain errors

6 protocols using gene specific sirna

1

Culturing and Transfecting Rat Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat cardiomyocytes (H9C2) were obtained from Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, and cultured in high-glucose DMEM and 10% heat-inactivated fetal bovine serum (FBS) supplemented with 100 U/mL penicillin and 100 g/mL streptomycin, at 37°C in a 95% air/5% CO2 incubator. Cells were transfected with siRNA using the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA). Gene-specific siRNA (5′-GGGUAAGUCGAGAAGUGUUTT-3′) for Nrf-2 and negative control siRNA were purchased from GenePharma (Shanghai, China). The transfection efficiency of RNA knockdown was estimated 48 h posttransfection by Western blotting.
Neonatal rat cardiomyocytes (NRCMs) were isolated from Sprague-Dawley (SD) rats as described previously [24 (link)]. Briefly, rat hearts were cut into pieces, washed with ice-cold hanks balanced salt solution (HBSS) three times, and incubated with 0.125% trypsin-EDTA for 15 minutes at 34°C for a total of five times. Then, the NRCMs were centrifuged via a differential attachment technique then seeded in six-well culture plates at a density of 2 × 105 cells per well. The isolated NRCMs were grown in DMEM containing 15% FBS supplemented with 100 U/mL penicillin and 100 g/mL streptomycin, at 37°C in a 95% air/5% CO2 incubator.
+ Open protocol
+ Expand
2

Gene-Specific siRNA Knockdown Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gene-specific siRNA was designed and synthesized by GenePharma (Shanghai, China). siRNA was transfected individually into cells using Lipofectamine RNAiMAX transfection reagent following the manufacturer’s instructions. The siRNA sequences were as follows: CHC siRNA, 5’-CCGGAAAUUUGAUGUCAAUACUUCA-3’; ASGR1 siRNA, 5’-GCUGCUUGUGGUUGUCUGUTT-3’; Negative-control siRNA, 5’-UUCUCCGAACGUGUCACGUTT-3’.
+ Open protocol
+ Expand
3

Transfection of NIH3T3 cells with siRNAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NIH3T3 cells were transfected with gene-specific siRNAs (GenePharma, Suzhou, China) and negative control siRNAs (GenePharma, Suzhou, China) using Lipofectamine RNAiMAX (Invitrogen, 13778500, Waltham, MA, USA) according to the manufacturer’s instructions. The following siRNA sequences were used: Atg5-1 siRNA (mouse: 5′-GGCAUUAUCCAAUUGGUUUTT-3′), Atg5-2 siRNA (mouse: 5′-GACGUUGGUAACUGACAAATT-3′), and nontargeting control siRNA (mouse: 5′-UUCUCCGAACGUGUCACGUTT-3′).
+ Open protocol
+ Expand
4

Gene-specific siRNA Knockdown Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gene-specific siRNAs and one non-targeting siRNA were purchased from GenePharma Co. ATG5#1 and ATG5#2 siRNAs target the sequences CCUUUG GCCTAAGAAGAAA and CAUCUGAGCUACCCGG AUA, respectively; ATG7#1 and ATG7#2 siRNAs target the sequences GGAGUCACAGCUCUUCCUU and CAGCUAUUGGAACACUGUA, respectively; Beclin1#1 and Beclin1#2 siRNAs target the sequences GGAA GCUCAGUAUCAGAGA and CAGUUUGGCACAAU CAAUA, respectively; LKB1#1 and LKB1#2 siRNAs target the sequences UGAAAGGGAUGCUUGAGUA and GAAGAAGGAAAUUCAACUA, respectively; AMPKα1 siRNA targets the sequence GAGGAGAGCUAUUUG AUUA; AMPKα2 siRNA targets the sequence GCUGU UUGGUGUAGGUAAA; ULK1 siRNA targets the sequence GCCUGUUCUACGAGAAGAA; while the sequence of the non-targeting control siRNA was 5′-UUCUCCGAACGUGUCACGUTT-3′.
+ Open protocol
+ Expand
5

Targeted siRNA Knockdown Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gene‐specific siRNAs and one non‐targeting siRNA were synthesized from GenePharma. ATG5#1 and ATG5#2 siRNAs target the sequences 5′‐CCT TTG GCC TAA GAA GAA A‐3′ and 5′‐CAT CTG AGC TAC CCG GAT A‐3′, respectively; ATG7 #1 and ATG7 #2 siRNAs target the sequences 5′‐GGA GTC ACA GCT CTT CCT T‐3′ and 5′‐CAG CTA TTG GAA CAC TGT A‐3′, respectively; Beclin1 siRNA targets the sequences 5′‐GGA AGC TCA GTA TCAGAGA‐3′; and AMPKα1 siRNA targets the sequence 5′‐GAGGAGAGC TAT TTG ATT A‐3′. The non‐targeting control siRNA targets the sequence 5′‐UUCUCCGAACGUGUCACGUTT‐3′.
+ Open protocol
+ Expand
6

Modulating YAP and PTEN in Lung Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human gene expression plasmids pcDNA3.1-YAP, pcDNA3.1-PTEN, gene-specific siRNAs, gene-specific shRNAs and control were from GenePharma (Shanghai, China). The target sequences were as follows: shPTEN1: GTCTGACCTAGTTAATTTACA; shPTEN2: GCAGGCTTCCAAAGGCTTATG; siYAP1: CUGCCACCAAGCUAGAUAATT; siYAP2: GCCAGUACUGAUGCAGGUATT; siLATS: GGUAGUUCGUCUAUAUUAUTT. Transfection of plasmids into A549 and H1299 cells were carried out using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturers’ instructions. Lipofectamine RNAiMAX (Invitrogen, USA) was used to transfect siRNAs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!